Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name ABBV-744
Trade Name
Synonyms ABBV744|ABBV 744
Drug Descriptions

ABBV-744 is a bromodomain II selective BET inhibitor that demonstrates anti-proliferative activity (Cancer Res 2018;78(13 Suppl):Abstract nr DDT01-05, PMID: 31969702, PMID: 32324999).

DrugClasses BET Inhibitor (Pan) 32
CAS Registry Number 2138861-99-9
NCIT ID C148415


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
ABBV-744 ABBV-744 0 2
ABBV-744 + Navitoclax ABBV-744 Navitoclax 0 1
ABBV-744 + Ruxolitinib ABBV-744 Ruxolitinib 0 1

Additional content available in CKB BOOST